TW202421145A - Kras g12c抑制劑之給藥方案 - Google Patents

Kras g12c抑制劑之給藥方案 Download PDF

Info

Publication number
TW202421145A
TW202421145A TW112124572A TW112124572A TW202421145A TW 202421145 A TW202421145 A TW 202421145A TW 112124572 A TW112124572 A TW 112124572A TW 112124572 A TW112124572 A TW 112124572A TW 202421145 A TW202421145 A TW 202421145A
Authority
TW
Taiwan
Prior art keywords
dosing regimens
kras
jpg
inhibitor dosing
img
Prior art date
Application number
TW112124572A
Other languages
English (en)
Inventor
大衛 赫曼
鞏學千
聖彬 潘
翀 斯
梅麗莎 戴爾 偉拉德
Original Assignee
美商美國禮來大藥廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商美國禮來大藥廠 filed Critical 美商美國禮來大藥廠
Publication of TW202421145A publication Critical patent/TW202421145A/zh

Links

Abstract

本文揭示一種給藥方案，用於向需要治療之患者投與式I化合物： <br/><img align="absmiddle" height="184px" width="283px" file="ed10040.JPG" alt="ed10040.JPG" img-content="jpg" orientation="portrait" inline="yes"/><br/>或其醫藥學上可接受之鹽，或與一或多種第二治療劑組合。 <u/>
TW112124572A 2022-06-30 2023-06-30 Kras g12c抑制劑之給藥方案 TW202421145A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63/357,227 2022-06-30
US63/486,785 2023-02-24
US63/496,447 2023-04-17

Publications (1)

Publication Number Publication Date
TW202421145A true TW202421145A (zh) 2024-06-01

Family

ID=

Similar Documents

Publication Publication Date Title
JP2023002662A5 (zh)
JP5767122B2 (ja) 特定の癌の治療のためのｒｄｅａ１１９／ｂａｙ８６９７６６を含む組み合わせ医薬
BRPI0115910B8 (pt) medicamento compreendendo 5-[(r)-2-(5,6-dietil-indan-2ilamino)-1-hidróxi-etil]-8-hidróxi-1h-quinolin-2-ona e corticóides para o tratamento de doencas inflamatórias ou obstrutivas das vias aéreas
JP2003509349A5 (zh)
CA2405796A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity
JPH10279482A (ja) ピリミジン誘導体の単独で又は他の治療方法と組み合わせた癌の予防のための使用
CA2440037A1 (en) Benzimidazole derivatives for modulating the rage receptor
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
CA2501322A1 (en) Quinolinyl-pyrrolopyrazoles
JP2019515884A5 (zh)
MXPA05003366A (es) Inhibidores de la proteina reguladora de conductancia transmembranal de la fibrosis quistica y usos de los mismos.
CA2620065A1 (en) Methods and formulations for modulating lyn kinase activity and treating related disorders
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
JP2004502732A5 (zh)
JP2020517736A (ja) 腎臓損傷の治療及び予防
CA2596084A1 (en) Treatment of metastasized tumors with quinolinone benzimidazole compounds
JP2007505044A5 (zh)
MX2021014161A (es) Metodos de tratamiento del sindrome de sjogren utilizando un inhibidor de la tirosina quinasa de bruton.
RU2007132971A (ru) Способы и материалы с транс-кломифеном для лечения мужского бесплодия
MX2021015447A (es) Métodos de tratamiento del cáncer dirigidos a tumores fríos.
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
MX2023003332A (es) Inhibidores del elemento 1 interdispersado largo (line-1) para el tratamiento de enfermedades.
TW202421145A (zh) Kras g12c抑制劑之給藥方案
EA200601286A1 (ru) Фармацевтические композиции, содержащие ингибитор протонового насоса и прокинетический агент
JP2002504512A5 (zh)